Skip to main content
. 2021 Jun 21;13(1):e12202. doi: 10.1002/dad2.12202

TABLE 5.

HABLE Characteristics – Blood Biomarker Biomarkers

Total Cohort N = 1705 Mexican American N = 890 Non‐Hispanic White N = 813
Plasma AT(N) Markers
Plasma A
Aβ40 252.55 (67.69) 239.25 (67.31) 267.30 (65.06)***
Aβ42 12.06 (3.31) 11.86 (3.41) 12.26 (3.18)
Plasma T (total tau) 2.47 (0.96) 2.57 (0.98) 2.35 (0.92)***
Plasma N (NfL) 18.97 (11.36) 17.31 (11.47) 20.81 (10.98)
Metabolic Endophenotype
PPY 634.01 (377.71) 606.95 (386.84) 660.91 (366.43)
PYY 44.26 (29.77) 41.81 (27.90) 46.63 (31.34)
GLP1 1.32 (1.64) 1.44 (1.83) 1.20 (1.14)
Insulin 295.65 (268.99) 344.47 (301.70) 247.07 (221.93)***
Glucagon 64.30 (44.83) 66.93 (46.08) 61.43 (43.00)***
FABP3 5032.94 (2267.02) 4619.31 (2259.08) 5487.06 (2187.72)
Inflammatory Endophenotype
IL6 1.32 (2.20) 1.42 (2.27) 1.21 (2.12)
CRP 42875365.58 (67985315.03) 44341610.06 (69216737.06) 41288343.28 (66691123.43)
TNFα 3.16 (1.03) 3.18 (1.04) 3.14 (1.00)

NOTE: All blood‐based biomarkers were capped at 4 SD above the mean.

***

p < 0.001 significance after controlling for covariates.